Progesterone suppresses interferon signaling by repressing TLR-7 and MxA expression in peripheral blood mononuclear cells of patients infected with hepatitis C virus

Archives of Virology

Volumn 158, Issue 8, 2013, Pages 1755-1764

  Tayel, Sara S ^a   Helmy, Amal A ^b   Ahmed, Rasha ^b   Esmat, Gamal ^b   Hamdi, Nabila ^a   Abdelaziz, Ahmed Ihab ^a  

^a German University in Cairo   (Egypt)

^b CAIRO UNIVERSITY   (Egypt)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS C VIRUS; ORTHOMYXOVIRIDAE;

EID: 84880763520     PISSN: 03048608     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00705-013-1673-z     Document Type: Article

References (32)

1. Akira S, Takeda K (2004) Toll-like receptor signalling. Nat Rev Immunol 4: 499-511.
2. Gilliet M, Cao W, Liu YJ (2008) Plasmacytoid dendritic cells: sensing nucleic acids in viral infection and autoimmune diseases. Nat Rev Immunol 8: 594-606.
3. Lund JM, Alexopoulou L, Sato A, Karow M, Adams NC, Gale NW, Iwasaki A, Flavell RA (2004) Recognition of single-stranded RNA viruses by toll-like receptor 7. Proc Natl Acad Sci USA 101: 5598-5603.
4. Smith PL, Lombardi G, Foster GR (2005) Type I interferons and the innate immune response-more than just antiviral cytokines. Mol Immunol 42: 869-877.
5. Williams BR (1991) Transcriptional regulation of interferon-stimulated genes. Eur J Biochem 200: 1-11.
6. Arnheiter H, Frese M, Kambadur R, Meier E, Haller O (1996) Mx transgenic mice-animal models of health. Curr Top Microbiol Immunol 206: 119-147.
7. Kittlesen DJ, Chianese-Bullock KA, Yao ZQ, Braciale TJ, Hahn YS (2000) Interaction between complement receptor gC1qR and hepatitis C virus core protein inhibits T-lymphocyte proliferation. J Clin Invest 106: 1239-1249.
8. Weber F, Kochs G, Haller O (2004) Inverse interference: how viruses fight the interferon system. Viral Immunol 17: 498-515.
9. Berghofer B, Frommer T, Haley G, Fink L, Bein G, Hackstein H (2006) TLR7 ligands induce higher IFN-alpha production in females. J Immunol 177: 2088-2096.
10. Escribese MM, Kraus T, Rhee E, Fernandez-Sesma A, Lopez CB, Moran TM (2008) Estrogen inhibits dendritic cell maturation to RNA viruses. Blood 112: 4574-4584.
11. Li X, Xu Y, Ma L, Sun L, Fu G, Hou Y (2009) 17beta-estradiol enhances the response of plasmacytoid dendritic cell to CpG. PLoS One 4: e8412.
12. Fawzy IO, Negm M, Ahmed R, Esmat G, Hamdi N, Abdelaziz AI (2012) Tamoxifen alleviates hepatitis C virus-induced inhibition of both toll-like receptor 7 and JAK-STAT signalling pathways in PBMCs of infected Egyptian females. J Viral Hepat 19: 854-861.
13. Mekky RY, Hamdi N, El-Akel W, Esmat G, Abdelaziz AI (2010) Estrogen-related MxA transcriptional variation in hepatitis C virus-infected patients. Transl Res 159: 190-196.
14. Dosiou C, Hamilton AE, Pang Y, Overgaard MT, Tulac S, Dong J, Thomas P, Giudice LC (2008) Expression of membrane progesterone receptors on human T lymphocytes and Jurkat cells and activation of G-proteins by progesterone. J Endocrinol 196: 67-77.
15. Hughes GC, Thomas S, Li C, Kaja MK, Clark EA (2008) Cutting edge: progesterone regulates IFN-alpha production by plasmacytoid dendritic cells. J Immunol 180: 2029-2033.
16. Kalo-Klein A, Witkin SS (1989) Candida albicans: cellular immune system interactions during different stages of the menstrual cycle. Am J Obstet Gynecol 161: 1132-1136.
17. Nelson JL, Ostensen M (1997) Pregnancy and rheumatoid arthritis. Rheum Dis Clin North Am 23: 195-212.
18. Marks MA, Gravitt PE, Burk RD, Studentsov Y, Farzadegan H, Klein SL (2010) Progesterone and 17beta-estradiol enhance regulatory responses to human papillomavirus type 16 virus-like particles in peripheral blood mononuclear cells from healthy women. Clin Vaccine Immunol 17: 609-617.
19. Yuan Y, Shimizu I, Shen M, Aoyagi E, Takenaka H, Itagaki T, Urata M, Sannomiya K, Kohno N, Tamaki K, Shono M, Takayama T (2008) Effects of estradiol and progesterone on the proinflammatory cytokine production by mononuclear cells from patients with chronic hepatitis C. World J Gastroenterol 14: 2200-2207.
20. Poynard T, McHutchison J, Goodman Z, Ling MH, Albrecht J (2000) Is an "a la carte" combination interferon alfa-2b plus ribavirin regimen possible for the first line treatment in patients with chronic hepatitis C? The ALGOVIRC project group. Hepatology 31: 211-218.
21. Gilli F, Marnetto F, Caldano M, Sala A, Malucchi S, Capobianco M, Bertolotto A (2006) Biological markers of interferon-beta therapy: comparison among interferon-stimulated genes MxA, TRAIL and XAF-1. Mult Scler 12: 47-57.
22. Ito M, Masumi A, Mochida K, Kukihara H, Moriishi K, Matsuura Y, Yamaguchi K, Mizuochi T (2010) Peripheral B cells may serve as a reservoir for persistent hepatitis C virus infection. J Innate Immun 2: 607-617.
23. Colonna M, Krug A, Cella M (2002) Interferon-producing cells: on the front line in immune responses against pathogens. Curr Opin Immunol 14: 373-379.
24. Saleh MA, Mekky RY, El-Ekiaby N, Hamdi N, Ahmed R, Zekri AR, Esmat G, Abdelaziz AI (2012) Potent inhibitory effects of p7 inhibitors on genotype 4 HCV-infected peripheral blood mononuclear cells. Recent Pat Biomark 2: 227-233.
25. Thomas A, Laxton C, Joanne R, Myangar N, Horscroft N, Parkinson T (2007) Investigating toll-like receptor agonists for potential to treat hepatitis C virus infection. Antimicrob Agents Chemother 51: 2969-2978.
26. El-Ekiaby N, Hamdi N, Negm M, Ahmed R, Zekri AR, Esmat G, Abdelaziz AI (2012) Repressed induction of interferon-related microRNAs miR-146a and miR-155 in peripheral blood mononuclear cells infected with HCV genotype 4. FEBS Open Bio 2: 179-186.
27. Shaker O, Ahmed A, Doss W, Abdel-Hamid M (2010) MxA expression as marker for assessing the therapeutic response in HCV genotype 4 Egyptian patients. J Viral Hepat 17: 794-799.
28. Chang S, Kodys K, Szabo G (2010) Impaired expression and function of toll-like receptor 7 in hepatitis C virus infection in human hepatoma cells. Hepatology 51: 35-42.
29. Osterlund P, Veckman V, Siren J, Klucher KM, Hiscott J, Matikainen S, Julkunen I (2005) Gene expression and antiviral activity of alpha/beta interferons and interleukin-29 in virus-infected human myeloid dendritic cells. J Virol 79: 9608-9617.
30. Peluso JJ, Fernandez G, Pappalardo A, White BA (2001) Characterization of a putative membrane receptor for progesterone in rat granulosa cells. Biol Reprod 65: 94-101.
31. Taylor MW, Tsukahara T, Brodsky L, Schaley J, Sanda C, Stephens MJ, McClintick JN, Edenberg HJ, Li L, Tavis JE, Howell C, Belle SH (2007) Changes in gene expression during pegylated interferon and ribavirin therapy of chronic hepatitis C virus distinguish responders from nonresponders to antiviral therapy. J Virol 81: 3391-3401.
32. Hannah MF, Bajic VB, Klein SL (2008) Sex differences in the recognition of and innate antiviral responses to Seoul virus in Norway rats. Brain Behav Immun 22: 503-516.